title: Fingolimod in a patient with Wolff-Parkinson-White syndrome.
authors.affiliation: Department of Clinical Neurosciences, Division of Neurology, University Hospital of Geneva, Switzerland.
authors.forename: Anne-Catherine Ml
authors.initials: AC
authors.lastname: Huys
authors.forename: Patrice H
authors.initials: PH
authors.lastname: Lalive
authors.forename: Lucka
authors.initials: L
authors.lastname: Sekoranja
mesh_terms: D000328:Adult; D004562:Electrocardiography; D005260:Female; D000068876:Fingolimod Hydrochloride; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine